4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: December 15, 2015
Period of Report: December 14, 2015
Accession Number: 0001144204-15-070834

View Document ↗ View on SEC.gov ↗